21.25
+1.25
+(6.25%)
At close: April 17 at 4:12:13 PM GMT+1
Breakdown
TTM
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Cash Flow
-2,726.32
-2,726.32
-2,645.14
-2,673.03
-1,555.05
Investing Cash Flow
-2,296.59
-2,296.59
-165.28
-96.81
-112.31
Financing Cash Flow
4,511.98
4,511.98
2,317.32
-35.12
4,118.19
End Cash Position
800.90
800.90
1,311.83
1,804.92
4,609.89
Capital Expenditure
-198.17
-198.17
-165.28
-96.81
-112.31
Issuance of Capital Stock
3,119.55
3,119.55
2,353.43
--
4,121.11
Issuance of Debt
1,472
1,472
--
--
--
Free Cash Flow
-2,924.49
-2,924.49
-2,810.41
-2,769.84
-1,667.35
6/30/2021 - 4/5/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OPTI.L OptiBiotix Health Plc
18.50
+2.78%
BT3.BE Lineage Cell Therapeutics Inc
0.3600
-1.10%
HQ1.MU Oruka Therapeutics Inc. R
7.50
+2.04%
MVR0.BE Medivir AB
0.1372
-2.42%
05Y.MU Vivoryon Therapeutics NV
1.7140
0.00%
PROT Proteonomix, Inc.
0.0000
0.00%
DBV.F DBV Technologies S.A.
1.2520
+1.79%
ICY.HA Incyte Corp
51.16
-0.31%
OMY.F Synairgen plc
0.0000
0.00%
HTD.MU Corcept Therapeutics Inc
57.90
-3.60%